News & Events
October 8, 2022
Hub71 Startup Alliance Care Technologies (ACT)
Brings First Locally Hosted EMR to the UAE on AWS
Alliance Care Technologies’ Catalyst Encounter is the first Electronic Medical Record (EMR) System to be hosted on AWS’s New Cloud Region in the United Arab Emirates.
This long anticipated milestone enables Alliance Care Technologies to utilize AWS advanced cloud technologies to spur innovation and achieve the highest levels of security, availability and resiliency. Alliance Care Technologies’ Catalyst Encounter CMS/EMR offers a simple workflow tool for recording patient notes and documentation. The solution acts as a centralized system of Electronic Medical Records (EMRs) that integrates with the surrounding clinical workflow ecosystem.
The introduction of the new AWS Middle East cloud region allows ACT to store data safely in the UAE. According to ACT’s CEO Michele Tarnow, “Local hosting with AWS means new opportunities for efficiency and greater emphasis on security. Catalyst Encounter is just one of many individualized, creative solutions we offer. We are excited to be a part of this health care transformation.”
Alliance Care Technologies’ Catalyst Encounter provides:
Electronic Medical Record (EMR)
Auto coding and billing with 99.67% approvals at 1st pass
EHR Integration into Health Information Exchange platforms
Telehealth and remote monitoring dashboards
Tap and touch real-time notes and diagnostic support
Natural Language Documentation
Cost Savings - 33% profitability, reduced FT cost of care
Workflow Optimization - automated data entry resulting in 30% reduction in documentation time
Data Availability - unstructured clinical data becomes +85% structured, streamlining processes and optimizing clinical insights
Low Implementation cost and minimum training
October 8, 2022
Connect with Alliance Care Technologies at GITEX Global, the world’s largest tech & start-up event
10-14 October, 2022 Zabeel Hall 6 - Hub71
ACT Founder & CEO Michele Tarnow will join AWS to digital transformation and cloud technology in the UAE
Visit ACT at the Hub71 booth, North Star – Za’abeel Hall 6, Z6-D412, between 11-2 pm where ACT team members will demonstrate how digital and AI solutions can improve healthcare outcomes across the continuum of care, featuring PTGenie Remote Physiotherapy & Assessments, CureMatch, Catalyst S4 and Catalyst Enounter - the first AWS, locally hosted Electronic Medical Records system in the UAE.
On Wednesday, ACT Founder & CEO Michele Tarnow will join AWS to provide an overview of ACT innovative healthcare solutions and share how ACT’s active AWS partnership has led to enhanced business opportunities and advanced digital solutions. According to Ms.Tarnow, “Working with AWS has expanded our technological reach and understanding. Our AWS partnership means we are better able to serve our clients needs.”
About Michele Tarnow and Alliance Care Technologies:
Michele Tarnow, founder and CEO Alliance Care Technologies is a leader in the international healthcare marketplace. Passionate about business and innovation, her experience includes new product identification, development marketing, healthcare informatics, artificial intelligence and advanced technology, and value-based healthcare solutions. She has assembled a global team of experienced professionals, innovators and entrepreneurs, enabling Alliance Care Technologies to become a leader in the global transformation of healthcare.
UAE-based Alliance Care Technologies develops advanced technology and AI solutions that aim to solve today’s most pressing healthcare challenges. The company partners with industry leaders to design individualized solutions to enhance patient experience, streamline administrative processes, manage costs and ultimately improve outcomes.
September 24, 2022
Future of Precision Medicine in Cancer Treatment
CureMatch, Inc. and Alliance Care Technologies Celebrate
World Cancer Research Day
Alliance Care Technologies is excited to introduce the CureMatch Decision Support System for Precision Medicine in the UAE. This free, hour-long webinar is designed for medical professionals, foundations and oncology support groups interested in advancing this groundbreaking decision support system in the MEASA region.
CureMatch brings precision oncology capability to more oncologists, cancer centers, NGS labs, concierge medicine providers – and their patients. The expertly and manually curated database leverages AI and evidence-based science to match, rank and score both known and novel combination therapies that address the patient's individual profile. The result is optimizing outcomes through Precision Medicine.
July 15, 2022
Alliance Care Technologies International and
US based CureMatch
Announce Strategic Partnership to Bring AI Precision Cancer Treatment to More Patients Worldwide
United Arab Emirates (July 15, 2022) — Alliance Care Technologies International (ACTI) and CureMatch, Inc., have announced a strategic partnership to bring the groundbreaking CureMatch Decision Support System to a greater number of markets, particularly in the MEASA (Middle East, Africa, South Asian) region. This agreement will give more doctors and patients worldwide access to an unprecedented suite of artificial intelligence (AI)-based SaaS oncology tools by CureMatch, focused on matching cancer patients with personalized treatments according to their genetic profile.
UAE-based ACTI develops advanced technology and AI solutions that aim to solve today’s most pressing healthcare challenges. The company partners with industry leaders to design individualized solutions to enhance patient experience, streamline administrative processes, manage costs and ultimately improve outcomes. Through this partnership, ACT will be able to license the CureMatch Decision Support System in order to bring this precision oncology capability to more doctors, hospital systems and other medical providers.
The CureMatch Decision Support System provides actionable intelligence to oncologists on therapy options matched specifically to an individual patient’s unique molecular tumor profile. The clinical decision support system leverages proprietary algorithms, as well as curated clinical and scientific knowledge, and provides a matching score to help doctors identify combinations and monotherapies for optimal cancer treatment.
Patients and providers working with ACTI will have access to all of the CureMatch Decision Support System services, including analysis reports for each prospective and/or retrospective patient’s genetic sequencing dataset, and consultations with CureMatch staff as needed for assistance interpreting the decision support system’s reports and recommendations.
“We are at an exciting time in oncology, where treatment options for tumor-specific therapies are being approved at increasing speed,” said Dr. Aaron Han, Chief Medical Officer of ACT. “CureMatch takes the specific genetic signature of a patient’s tumor, and finds the best treatment and combination based on a proven algorithm. Precision medicine in oncology is here now!”
“CureMatch is a solution that will enable physicians to apply advances in precision medicine in oncology to their specific areas of expertise, directly benefiting individual patients' treatment and outcomes” said Michele Tarnow, Founder & CEO of ACT. “As new therapies rapidly emerge, the CureMatch Decision Support System will be a critical resource for oncologists who may struggle to stay informed about new therapeutic combinations and trials.”
“Cancer knows no borders or boundaries, and neither do we,” said Navid Alipour, CEO of CureMatch. “No two cancers are the same, but with our AI technology, we can help deliver better outcomes by helping oncologists process the vast volume of information in genetic sequencing reports, and prescribe therapies customized to their patient’s molecular profile. It is beyond human cognition to process the over 4.5 million possible three-drug combinations that could fight any given person’s cancer. That is why it’s so critical that doctors have access to our proprietary KRR (Knowledge, Representation & Reasoning) AI to “CureMatch” the patient to the correct treatment the first time.”
Continued Alipour: “We are thrilled to work with ACTI for a number of reasons. The UAE has become a hub of medical tourism and innovation for both the MEASA region and beyond. The leadership at Alliance Care Technologies is committed to optimizing patient care and improving outcomes, while reducing costs for hospitals and patients alike. Their mission aligns directly with CureMatch’s patient-centric approach to genetic testing and AI solution development, and we cannot wait to work together to expand our solution worldwide.”
For more information or to arrange an interview, please contact:
Michele Tarnow, CEO, Alliance Care Technologies International
Michele.Tarnow@alliancecaretech.com or call +971.50386.1117
About Alliance Care Technologies
Driven by a vision for equitable, universal access to value based healthcare, Alliance Care Technologies develops and deploys advanced technology and artificial intelligence solutions that solve today's most pressing healthcare challenges. We work with physicians, patients, researchers, industry leaders, and entrepreneurs, to design individualized solutions that enhance the patient experience, streamline administrative processes, manage costs, and ultimately, improve healthcare outcomes across the continuum of healthcare. ACT is a proud winner of the 2021 Hub71 Outliers Competition and a member of Hub71’s 2022 cohort. https://www.alliancecaretech.com/
CureMatch is a leader in precision medicine digital solutions. Created on the belief that oncologists everywhere should benefit from world-class research, the CureMatch Decision Support System helps guide oncologists in the selection of cancer drugs that are customized for individual patients based on the molecular profile of their tumor, allowing each oncologist to become an expert in personalized medicine for better patient outcomes. www.CureMatch.com
May 22, 2022
Dr. Aaron Han, Chief Medical Office
Keynote Speaker at PrecisionMed Conference
Alliance Care Technologies Chief Medical Officer Dr. Aaron Han, MD, PhD Shares Insights at PrecisionMed Conference 2022
Alliance Care Technologies’ Chief Medical Officer, Dr. Aaron Han, MD, PhD, will be sharing his insights on the future of healthcare within the Gulf Cooperative at this year’s PrecisionMed Exhibition & Summit, in Dubai on 24-25 May. Dr. Aaron Han will join leading experts and thought leaders discussing new developments in the area of precision medical technologies.
Presenting on PMES Mainstage on Wednesday 25 May at 1:45 pm, Dr. Han’s presentation will focus on “COVID-19: Lessons Learned from Precision Medicine and Hematology”.
According to Michele Tarnow, CEO of Alliance Care Technologies “ACT is privileged to have Dr. Han as our Chief Medical Officer. We are excited to join Dr. Han at the PrecisionMed Summit and look forward to learning more about how Catalyst S4 Solution enhances recent developments in targeted, precision medicine that will have a critical impact on the future of healthcare in this region and beyond.”
About Aaron Han, MD, PhD:
Aaron Han, MD, PhD, is a Consultant Pathologist with a special interest in hematology and coagulation disorders. An MD and PhD from Baylor College of Medicine, Dr Aaron is American Board Certified in Anatomic and Clinical Pathology and holds a special qualification in Hematology. He holds a joint faculty appointment at Mohammed bin Rashid University School of Medicine. Dr. Han is the Group Chair of Pathology for King’s College of London Middle East.
Dr. Aaron has served decades of USA and Middle East clinical and educational leadership experience. He is a sought-after speaker. Dr. Aaron is a passionate visionary leader driving medical informatics innovation, quality, and growing leaders. Mentor and board member. Dr Han cares about people, process, policy, and tech platforms.
About PrecisionMed Summit:
PrecisionMed Exhibition & Summit, in Dubai on 24-25 May provides a unique opportunity for healthcare providers, academic scientists and industry experts in this ecosystem to share knowledge and make connections.
Precision medicine describes the evolving world of personalised medicine and including the use of biomarkers, targeted therapies and the integration of patient health data to translate scientific advances into human health.
Personalised solutions have gained wide traction in genomics & targeted cancer therapies; regenerative medicine, and now include a wide range of diagnostics and treatments for both rare and common diseases.
For more information about the Summit and to register to attend, please visit: https://precisionmedexpo.com/
About Alliance Care Technologies
Alliance Care Technologies International (ACTI) is driven by a mission to provide global access to quality healthcare. At Alliance Care Technologies International, we believe global health is improved when physicians, patients, researchers and entrepreneurs work together to improve quality and efficiency across the continuum of healthcare.
Alliance Care Technologies develops and deploys advanced technology and artificial intelligence solutions that solve today's most pressing healthcare challenges. We work with industry leaders to design individualized solutions that enhance the patient experience, streamline administrative processes, manage costs, and ultimately, improve healthcare outcomes. https://www.alliancecaretech.com/
For more information or to arrange an interview, please contact
Alliance Care Technologies
May 16, 2022
ACT's Catalyst S4 System Recognized by Fast Company’s
2022 World Changing Ideas Awards
Alliance Care Technologies (ACT) was recently recognized in Fast Company’s 2022 World Changing Ideas Awards in the “On The Rise” category, highlighting ACT’s innovative S4 Symptoms Surveillance System.
The winners of Fast Company’s 2021 World-Changing Ideas Awards honor the businesses, policies, projects and concepts that are actively engaged and deeply committed to pursuing innovation when it comes to solving health and climate crises, social injustice or economic inequality. Now in its fifth year, the World-Changing Ideas Awards showcases some of the world’s most inventive entrepreneurs and companies tackling exigent global challenges.
How Catalyst S4 can change global response to the spread of global pathogens:
Alliance Care Technologies’ S4 System is an innovative, symptom-based, syndromic surveillance system that identifies dangerous pathogens at the pre-pandemic stage. S4 uses artificial intelligence to analyze symptom data and compare to predefined patterns of pathogens of interest. Catalyst S4 increases the likelihood that pandemic and Bioterrorism Pathogens and other infectious diseases are identified pre-diagnosis, allowing time for public health professionals to intervene and prevent the spread of dangerous infectious diseases.
“We were thrilled to receive an Honorable Mention recognizing our innovative Catalyst S4 Symptoms Surveillance System alongside these other innovators,” said ACT’s Founder and CEO, Michele Tarnow. S4 promises to revolutionize the way global leaders respond to the spread of potential pathogens, significantly speeding response time and ultimately avoiding future pandemics.”
About Fast Company’s World-Changing Ideas Awards:
World-Changing Ideas is one of Fast Company’s major annual awards programs and is focused on social good, seeking to elevate finished products and brave concepts that make the world better. A panel of judges from across sectors choose winners, finalists, and honorable mentions based on feasibility and the potential for impact. With the goals of awarding ingenuity and fostering innovation, Fast Company draws attention to ideas with great potential and helps them expand their reach to inspire more people to start working on solving the problems that affect us all. https://www.fastcompany.com/90614743/world-changing-ideas-awards-2021-on-the-rise-0-4-years-in-business-finalists-and-honorable-mentions
May 14, 2022
The Future of Biotech R&D in the UAE
Dr. Aaron Han, MD, PhD, Alliance Care Technologies Chief Medical Officer to speak at
Dubai Science Park
Alliance Care Technologies’ Chief Medical Officer and Chairman of the Board of Directors, Aaron Han, MD, PhD, will join a panel of experts to discuss the UAE’s role in driving innovation from within to improve healthcare locally, regionally, and globally.
The esteemed panel, moderated by Marwan Abdulaziz Janahi, Managing Director of Dubai Science Park, will be discussing innovation from the perspectives of pharma, investment, hospitals, academia, and SME.
Dr. Aaron will join expert panelists Dr. Nadine Tarcha, Medical Director, Gulf at Pfizer and Dr. Hemad Yasael, Dubai Genetics Center, Pathology and Genetics Department, Dubai Health Authority to share his knowledge and insights into the future R&D innovation in UAE Healthcare
The Advance Health Forum brings together healthcare stakeholders and key opinion leaders in the UAE. Healthcare is a central part of UAE’s strategic goals, with priorities including healthcare of the highest international standards, innovation in e-health and smart health, and world-leading medical tourism. This session will explore how the UAE is driving innovation from within to improve health care locally, regionally, and globally. innovation from within to improve healthcare locally, regionally, and globally.
About Aaron Han, MD, PhD:
Aaron Han, MD, PhD, is Chief Medical Officer for Alliance Care Technologies. He is a Consultant Pathologist with a special interest in hematology and coagulation disorders. An MD and PhD from Baylor College of Medicine, Dr Aaron is American Board Certified in Anatomic and Clinical Pathology and holds a special qualification in Hematology. He holds a joint faculty appointment at Mohammed bin Rashid University School of Medicine. Dr. Han is the Group Chair of Pathology for King’s College of London Middle East.
January 24, 2022
Alliance Care Technologies Joins Abu Dhabi’s Prestigious Hub71 Global Tech Ecosystem
Alliance Care Technologies announces it has joined Abu Dhabi’s Hub71’s global tech ecosystem. ACT is one of only 16 startups invited to the 2022 cohort, and joins a growing community focused on accelerating the Emirate’s position as a leading innovation hub.
The new startup cohort, which has already raised more than AED 231 million in funding, will have the opportunity to develop advanced technologies and gain access to the market, investment, and talent Hub71 provides.
“We are honored to be chosen for this year’s cohort, and excited to discover how we can work together with other founders to achieve our goals.” According to Michele Tarnow, Founder and CEO of Alliance Care Technologies, “By joining Hub71, will gain access to Abu Dhabi’s innovation ecosystem with opportunities to scale and facilitate knowledge exchange. This is an unparalleled opportunity for ACT. Our team can’t wait to get started.”
Hub71 is Abu Dhabi’s largest community of startups, building a vibrant ecosystem of investors, corporations, government, and academia partners to provide tech startups with the essential elements to grow and succeed in the UAE and abroad.
Microsoft, SoftBank Vision Fund and Mubadala Investment Company are founding partners of this new initiative, working in close collaboration with Abu Dhabi Global Market (ADGM) to bring together capital providers, business enablers and strategic partners.
Named after the year the UAE was formed, Hub71 and partners provide meaningful access to top investors, world-class customers, expert mentorship and lucrative market opportunities. Its Incentive Program alleviates the cost of setting up and living in Abu Dhabi for innovative tech startups. https://www.hub71.com/
About Alliance Care Technologies (ACT)
Alliance Care Technologies is driven by a vision for equitable, universal access to value based healthcare.
Alliance Care Technologies develops and deploys advanced technology and artificial intelligence solutions that solve today's most pressing healthcare challenges. We work with physicians, patients, researchers, industry leaders, and entrepreneurs to design individualized solutions that enhance the patient experience, streamline administrative processes, manage costs, and ultimately, improve healthcare outcomes across the continuum of healthcare. https://www.alliancecaretech.com/
January 24, 2022
ACT at Arab Health 2022
We are grateful to be invited by Dubai Science Park as an innovator and high-quality digital health solution provider, made in UAE to present our solutions at Arab Health Exhibition in their booth (CC72) on Monday 24th. Alliance Care Technologies presents PT Genie, Sectra, Catalyst S4, and Aircoder.
October 20, 2021
ACT wins DOH & Hub 71 Healthcare challenge
Alliance Care Technologies selected as a winner of a healthcare challenge focused on early infectious disease detection. ACT's S4 - Symptoms-based Syndromic Surveillance System will be implemented by Department of Health, as part of Proof-of-Concept.
ACT Ranked Among the Top 100 Medical Startups Worth Watching in 2020
This article showcases Startup Pill’s top picks for the best Medical Device startups. These startups are taking a variety of approaches to innovating inside of the medical device industry and around the world. They are all exceptional startups well worth a follow.
We selected these startups for exceptional performance in one of these categories:
Innovative route to market
Exceptional growth strategy
Synapse and Alliance Care Technologies partner to offer automated clinical coding software internationally
Synapse Medical Services, the Australian company with an AI driven automated coding system that can code up to 10 episodes per second, and Alliance Care Technologies, an American company with unique technologies that are tailored to assist physicians across the entire continuum of care, are delighted to announce a reseller partnership to offer the platform to both networks and in the various jurisdictions that they cover.
Synapse CEO, Margaret Faux, said it was so exciting to finally enter into an agreement with ACT after building a strong relationship over the last few years with their Dubai office and sharing a vision around using cutting edge technology to support the highest quality of clinical care.
By partnering with Alliance Care Technologies, Aircoder can be nicely plugged into their already impressive array of clinical and business solutions to offer more depth to their practice management offering. Faux said that the partnership made sense to “support the existing solutions offered by ACT with a complimentary platform whilst reaching a larger network due to the countries that both companies operate in”.
Alliance Care Technologies aim to improve the delivery of value-based healthcare through algorithm-based smart tools, having built an allied team of independent tools and aggregated them to optimize care. This made the partnership a very logical step for both sides.
ACT CEO, Michele Tarnow, said “We are delighted to partner with Synapse to offer their automated coding solution to our network and build a long-term partnership. The AI solution fits perfectly with our existing suite of services as we already deploy our AI based tools to look at improving assessment, clinical quality and efficiencies with our international healthcare partners. Improving collection of clinical data and effectively using the results arising from that will be a key driver for all going forward. This partnership is an exciting next step”.
Ms Faux, Synapse CEO, added “We have known Michele for a while now and feel that ACT’s core values align with our own. We both have a Dubai based office in Dubai Science Park and look forward to working closely from this hub to develop an international plan. Both companies are passionate about innovative products that can fuel positive results and reduce healthcare wastage, both from a resource and financial perspective. Aircoder does this and we welcome the chance to make this agreement public”.
COVID has presented many new challenges for healthcare systems the world over with technology becoming more important than ever. Aircoder was launched in December 2019 after years of internal development and built to assist with the shortage of clinical coders the world over. This agreement will allow the platform to be used to support clients in the Middle East, America and Australia as it can be trained to code any code set in the world.
Through this partnership both sides will be providing all of the necessary technology, administrative support, and an automated coding service to ensure that more international healthcare facilities have the option to perfect the recording of their clinical data and associated payments.
Alliance Care Technologies will be participating 11th & 12th August in the Riyadh Global Digital Health Summit (RGDHS), bringing together leaders of healthcare systems, public health, digital health, academic institutions and businesses to discuss the vital role of digital health in the fight against current and future pandemics.
The virtual two-day summit, organised by the Ministry of National Guard’s Health Affairs Department, in collaboration with the Saudi Center for International Strategic Partnerships, is part of the G20 calendar under the Kingdom of Saudi Arabia’s presidency. It follows the G20 Extraordinary Summit held on 26th March 2020, during which G20 member countries expressed their commitment to providing a united front to combatting COVID-19.
A well-structured event programme will represent all aspects of digital health and ensure a wide participation from experts across the world.
Faisal Almajed, RGDHS spokesman and a General Director at the King Saud bin Abdulaziz University for Health Sciences, commented: “The pandemic has undoubtedly accelerated appreciation for technological solutions, so healthcare professionals must now seize this opportunity to build on previous strides forward in digital health and advocate for accelerated digitalization as a core part of countries’ recovery plans.
To register for this event go to: https://rgdhs2020.com/.